Lisa Pasterk

538 total citations
17 papers, 385 citations indexed

About

Lisa Pasterk is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Lisa Pasterk has authored 17 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pharmacology. Recurrent topics in Lisa Pasterk's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Platelet Disorders and Treatments (2 papers). Lisa Pasterk is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Platelet Disorders and Treatments (2 papers). Lisa Pasterk collaborates with scholars based in Austria, Switzerland and United Kingdom. Lisa Pasterk's co-authors include Gunther Marsche, Ákos Heinemann, Sanja Ćurčić, Michael Holzer, Markus Trieb, Rudolf Schicho, Vanessa Stadlbauer, Peter Wolf, Angela Horvath and Wolfgang Weger and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Investigative Dermatology.

In The Last Decade

Lisa Pasterk

17 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Pasterk Austria	12	111	101	69	66	63	17	385
Bing Du China	13	150 1.4×	136 1.3×	44 0.6×	76 1.2×	45 0.7×	29	504
Sun Woo Kang South Korea	9	106 1.0×	113 1.1×	66 1.0×	83 1.3×	45 0.7×	18	515
Shirong Cao United States	15	254 2.3×	170 1.7×	52 0.8×	70 1.1×	94 1.5×	23	690
Hiroyuki Kadoya Japan	15	169 1.5×	39 0.4×	42 0.6×	95 1.4×	56 0.9×	34	550
Miaoxia Pan China	10	262 2.4×	143 1.4×	39 0.6×	69 1.0×	53 0.8×	15	516
Alexandros Sachinidis Greece	11	147 1.3×	126 1.2×	70 1.0×	116 1.8×	44 0.7×	18	603
Masahito Ogiku Japan	10	73 0.7×	84 0.8×	47 0.7×	43 0.7×	94 1.5×	19	357
Jinshan Wu China	11	145 1.3×	89 0.9×	68 1.0×	77 1.2×	69 1.1×	16	515
Weiyan Lai China	9	139 1.3×	79 0.8×	50 0.7×	28 0.4×	39 0.6×	15	389

Countries citing papers authored by Lisa Pasterk

Since Specialization

Citations

This map shows the geographic impact of Lisa Pasterk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Pasterk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Pasterk more than expected).

Fields of papers citing papers by Lisa Pasterk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Pasterk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Pasterk. The network helps show where Lisa Pasterk may publish in the future.

Co-authorship network of co-authors of Lisa Pasterk

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Pasterk. A scholar is included among the top collaborators of Lisa Pasterk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Pasterk. Lisa Pasterk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bonetti, Nicole R., Annukka Jouppila, Seyed Soheil Saeedi Saravi, et al.. (2023). Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice. Thrombosis Research. 228. 163–171. 3 indexed citations

Gaul, Daniel S., Nicole R. Bonetti, Yu-Jen Wang, et al.. (2022). Endothelial SIRT6 deficiency promotes arterial thrombosis in mice. Journal of Molecular and Cellular Cardiology. 174. 56–62. 13 indexed citations

Bonetti, Nicole R., Luca Liberale, Alexander Akhmedov, et al.. (2021). Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke. Atherosclerosis. 325. 89–98. 11 indexed citations

Saravi, Seyed Soheil Saeedi, Nicole R. Bonetti, Benoı̂t Pugin, et al.. (2021). Lifelong dietary omega-3 fatty acid suppresses thrombotic potential through gut microbiota alteration in aged mice. iScience. 24(8). 102897–102897. 19 indexed citations

Frick, Marcel, Michael Liu, Seyed Soheil Saeedi Saravi, et al.. (2021). Reduced adrenal stress response in patients on PCSK9 inhibitor therapy. Atherosclerosis. 325. 63–68. 1 indexed citations

Reiner, Martin F., Daniel J. Müller, Odile Stalder, et al.. (2018). Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism. Thrombosis Research. 174. 40–47. 27 indexed citations

Ćurčić, Sanja, Michael Holzer, Lisa Pasterk, et al.. (2017). Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation. Scientific Reports. 7(1). 8030–8030. 28 indexed citations

Trieb, Markus, Angela Horvath, Ruth Birner‐Gruenberger, et al.. (2016). Liver disease alters high-density lipoprotein composition, metabolism and function. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(7). 630–638. 72 indexed citations

Theiler, Anna, Viktória Kónya, Lisa Pasterk, et al.. (2016). The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation. Vascular Pharmacology. 87. 180–189. 10 indexed citations

10.

Winnik, Stephan, Daniel S. Gaul, Christine Lohmann, et al.. (2016). Mild endothelial dysfunction in Sirt3 knockout mice fed a high-cholesterol diet: protective role of a novel C/EBP-β-dependent feedback regulation of SOD2. Basic Research in Cardiology. 111(3). 33–33. 29 indexed citations

11.

Ribitsch, Werner, Gernot Schilcher, Gunther Marsche, et al.. (2016). Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease. Scientific Reports. 6(1). 34534–34534. 17 indexed citations

12.

Pasterk, Lisa, Bettina Leber, Markus Trieb, et al.. (2016). Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression. Scientific Reports. 6(1). 22104–22104. 23 indexed citations

13.

Pasterk, Lisa, Sonia Philipose, Kathrin Eller, et al.. (2015). The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions. Pharmacology. 96(3-4). 137–143. 11 indexed citations

14.

Ćurčić, Sanja, Michael Holzer, Lisa Pasterk, et al.. (2014). Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(2). 184–193. 44 indexed citations

15.

Holzer, Michael, Peter Wolf, Martin Inzinger, et al.. (2013). Anti-Psoriatic Therapy Recovers High-Density Lipoprotein Composition and Function. Journal of Investigative Dermatology. 134(3). 635–642. 66 indexed citations

16.

Philipose, Sonia, Viktória Kónya, Lisa Pasterk, et al.. (2012). Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation. PLoS ONE. 7(8). e40222–e40222. 10 indexed citations

17.

Philipose, Sonia, Viktória Kónya, Lisa Pasterk, et al.. (2012). Laropiprant attenuates EP3and TP prostanoid receptor-mediated thrombus formation. BMC Pharmacology and Toxicology. 13(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact